DLEXY yields 129.03% · PFE yields 6.13%● Live data
📍 DLEXY pulled ahead of the other in Year 1
Combined, DLEXY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DLEXY + PFE for your $10,000?
Datalex plc develops and sells various distribution and retailing software products and solutions to the airline industry in Ireland, the Americas, the Asia Pacific, the United Kingdom, and rest of European countries. The company operates in two segments, E-Business and TPF Consulting. It offers Datalex Direct, a customer-centric digital commerce product for travel retailing through airlines' direct channels; Datalex Merchandiser that enables airlines to deploy intelligent merchandising strategies across channels and touchpoints, generates ancillary revenue, and optimizes traveler engagement at various point in their journey; Datalex NDC, which provides end-to-end offer and order management for indirect channel using NDC; and Datalex Dynamic, which creates and optimizes capabilities by allowing airlines to build customer centric, contextualized, and personalized offers for air and non-air products. The company also provides Datalex China Shopping and Pricing Engine, an air shopping and pricing solution for Chinese airlines; and Datalex Pricing AI, a real-time pricing product. In addition, it delivers professional and hosting services; and offers online payment processing connectivity services, as well as IT consultancy services to airlines. Datalex plc was founded in 1985 and is headquartered in Dublin, Ireland.
Full DLEXY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.